Gilead's Trodelvy suffers double whammy as failed bladder cancer trial raises flag over early deaths

Following a high-profile lung cancer setback in January, Gilead said Thursday Trodelvy also failed to move the needle in a bladder cancer study.

Related Keywords

California ,United States ,Merck Keytruda ,Daiichi Sankyo ,Astella Netcin ,Merck Co ,Astrazeneca ,Pfizer ,Kelun Biotech ,